Would you sign up to catch a deadly disease and live in isolation for weeks? These friends did cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
When the COVID-19 pandemic hit, Canada was caught off balance and had to rely on foreign suppliers for the millions of vaccine doses it needed. A new facility in Montreal could mean domestically produced vaccines will be available if booster shots or new vaccines are needed.
Evening Brief: Navigating a post-pandemic world By iPolitics. Published on Mar 12, 2021 5:56pm Prime Minister Justin Trudeau speaks to reporters in Ottawa on July 8. (Andrew Meade/iPolitics)
Today’s Evening Brief is brought to you by News Media Canada. It’s time to level the digital playing field. Google and Facebook are using their monopoly to threaten and undermine local news. Other countries are taking action. It’s time for Canada to stand up to the web giants – and step up for local news. Learn more.
Good evening to you.
As people look ahead to how we’re going to navigate the post-pandemic world, it’s not clear if we’ll be doing it with a vaccine passport in hand. Today, Prime Minister Justin Trudeau made it clear he’s pretty cool on the idea of having people prove they’ve been vaccinated, suggesting it could unfairly impact some who may not be able to get vaccinated because of medical conditions or other reasons. There’s also the reality that
A waste of a lot of time : Researcher in CanSino deal shares new details ipolitics.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipolitics.ca Daily Mail and Mail on Sunday newspapers.
The trial was designed as a combined Phase 1/Phase 2 study. Phase 1 will vaccinate 108 healthy volunteers in a placebo-controlled study at the Canadian Center for Vaccinology (CCfV) in Halifax. Two doses will be administered to each volunteer 28 days apart. “The goal of this trial is to help demonstrate vaccine safety in people,” said CCfV principal investigator Dr. Joanne Langley. “As part of this, we will monitor the health of the volunteers for a year after their vaccination.” VIDO has worked on infectious disease vaccine projects with CCfV, the most recognized site in the country for vaccine clinical trials, for more than a decade.